MouseScan™ PhIP-Seq Antibody Profiling Service

High-throughput Murine Autoantibody Profiling

Murine proteome epitope-level autoantibody profiling services via T7 phage immunoprecipitation sequencing (PhIP-Seq)

REQUEST INFO

Epitope-level Antibody Discovery Against the Entire Murine Proteome

MouseScan™ analyzes preclinical murine samples for the presence of autoantibodies against the full GRCm38.p5 mouse proteome in a single-well assay with quantitative sequencing readouts.

MouseScan PhIP-Seq Library Curation and Production

MouseScan enables simultaneous epitope-level autoantibody profiling against an entire murine proteome via phage immunoprecipitation sequencing (PhIP-Seq).

MouseScan PhIP-Seq Library Curation and Production Figure

MouseScan PhIP-Seq Methods and Analysis

MouseScan enables simultaneous epitope-level autoantibody profiling against an entire murine proteome.

MouseScan PhIP-Seq Methods and Analysis Figure


MouseScan™ Services at CDI Labs

Technical Details

The first whole proteome murine autoantibody discovery platform reported; the first available commercially. Each protein in the GRCm38.p5 mouse proteome was downloaded and divided into 62-amino acid peptides with 19-AA overlap. Redundant sequences from identical regions of the different isoforms and homologs were eliminated if they had >95% identity overlap. The final library contains 482,672 unique peptide sequences that represent a full murine proteome of 50,135 proteins and protein isoforms.

This was ordered as an oligonucleotide library, PCR-amplified with adaptors for cloning, and packaged into a T7 phage display vector that was expanded in E. Coli. An aliquot from this library is then reacted with diluted patient serum or other antibody-containing fluid. Bound antibodies are immunoprecipitated with protein A/G beads, the precipitate amplified by PCR, and the sequences quantified by a next-generation sequencing and analysis pipeline that compares patient-sample IP read counts to negative controls with no antibody input (mock IPs) in the context of overall clonal frequency of individual peptides in the parent library. Output data are then created at both the peptide level.

Service Details and Data Deliverables

MouseScan service involves case and control serum or plasma samples. These undergo a protein A/G pulldown assay, PCR amplification, and next-generation sequencing. Raw sequence data are run through a normalization and quantitation pipeline. Raw pipeline counts outputs are then provided to customers alongside normalized hit calls data for all individual 62-mer peptides.

Sample Requirements

Serum or plasma20 μL aliquot per sample
Cerebrospinal fluid (CSF)250 μL aliquot per sample
Other antibodies (IgG monoclonals, B cell supernatants, etc)250 μL aliquot per sample at 0.01 mg/mL concentration
12 sample minimumSold in multiples of x12 samples (i.e., x12, x24, x36, x48 – full rows of a standard 96-well plate), and any number after 48 samples
Cohort balancing (studies bigger > 336 samples)

Individual PhIP-Seq studies are prepared in x96 well plates using aliquots of our phage library; each study requires x48 controls pooled plasma, known polyclonal, and protein A/G beads-only internal control samples per sequencer run (provided free-of-charge). Data are most reproducible within a single sequencer run. Sequencer runs are currently limited to 4x 96-well plates (336 experimental samples + x48 controls per run).

Sample Shipping and Sample Return

We will include shipping details in your quote – you must cover the cost of shipping samples to CDI Labs. Typically, after you receive your report, CDI Labs keeps the remaining samples for two months and then disposes of them. When shipping to us, please let us know if you want the remaining samples returned after the study is complete. Return shipping will be charged.

Ready to Transform Your Research?

Discover how MouseScan PhIP-Seq can revolutionize your understanding of murine immune responses
and accelerate your research breakthroughs.

REQUEST INFO / QUOTE

What Our Customers Are Saying

"With CDI Labs, identifying antibodies and their targets has never been so simple. Their passionate team, robust science and high-quality service unlock the discovery of new mechanisms, biomarkers and therapeutic targets."

Matthieu Roulleaux DugageGustave Roussy View poster, "Baseline serum level of IgG targeting annexin A2 is predictive of response to immunotherapy in patients with advanced NSCLC" presented at IMMUNOLOGY 2025

What Our Customers Are Saying

"We enjoyed working with CDI Labs. We used both VirScan and HuScan services from CDI Labs as part of our neurodegenerative disease research. The team at CDI Labs was very responsive and great to work with, and they went above and beyond to get us our results very quickly. They were particularly helpful in making contract arrangements and ensuring that everything was in place for a smooth collaboration. CDI Labs also provided a comprehensive statistical analysis, which will be invaluable as we build on our research. We’re still analyzing the data, but we’re confident that we’ll gain new insights into disease mechanisms that will advance our research."

Wouter Peelaerts, PhDProfessor, KU Leuven

What Our Customers Are Saying

"CDI Labs provide consistent service and consistently high-quality protein array products to our lab. Their sales and scientific team are courteous and timely in their responses to our queries.”

Dr. Andrew McKeonMayo Clinic College of Medicine & Science

Data and Technology Validated by Scientists

"We elected to use the HuProt Microarray because it is an extensive platform that contains over 21,000 unique, individually purified full-length human proteins and protein isoforms in duplicate, covering more than 81% of the proteome."

OncologistSchool of Medicine Research (as mentioned in "Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint Blockade" - AACR Clinical Caner Research - September 2022)

Data and Technology Validated by Scientists

"This (VirScan) assay, which uses phage display immunoprecipitation and sequencing, is a sensitive and focused high-comprehensive approach that enables thorough serological profiling of antiviral antibodies in humans and, consequently, the identification of viral exposure throughout the human virome."

Faculty of MedicineResearch Institution (as mentioned in "Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8+ T cells in patients with advanced NSCLC" - Science Advances - November 2023)

Data and Technology Validated by Scientists

"By using (HuProt) protein arrays, we were able to evaluate a broader range of antigens compared to previous investigations."

Senior ScientistBiotech Research (poster presentation at the San Antonio Breast Cancer Symposium 2023)